Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements Of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Treasury Stock
Total
Beginning balance, shares at Dec. 31, 2018 2,774,394 810,856          
Beginning balance, value at Dec. 31, 2018 $ 2,774 $ 811 $ 168,170,244 $ (153,233,595) $ 253,734 $ (5,281,180) $ 9,912,788
Issuance of common stock and warrants in registered direct offering, net of issuance costs, shares 86,667          
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value $ 87 2,698,963 2,699,050
Exercise of pre-funded warrants, shares 42,417          
Exercise of pre-funded warrants, value $ 42 467 509
Issuance of common stock to vendor, shares 7,836          
Issuance of common stock to vendor, value $ 7 (7)
Issuance of common stock to adjust for reverse split rounding, shares 1,442          
Issuance of common stock to adjust for reverse split rounding, value $ 1 (1)
Deemed dividend related to Series B Preferred Stock down round provision 3,879,447 3,879,447
Accretion of deemed dividend related to Series B Preferred Stock down round provision (3,879,447) (3,879,447)
Share-based expense 450,667 450,667
Common stock awards to vendors 32,427 32,427
Net loss (2,704,650) (2,704,650)
Ending balance, shares at Jun. 30, 2019 2,774,394 949,218          
Ending balance, value at Jun. 30, 2019 $ 2,774 $ 948 171,352,760 (155,938,245) 253,734 (5,281,180) 10,390,791
Beginning balance, shares at Mar. 31, 2019 2,774,394 897,523          
Beginning balance, value at Mar. 31, 2019 $ 2,774 $ 898 171,103,147 (154,560,845) 253,734 (5,281,180) 11,518,528
Exercise of pre-funded warrants, shares 42,417          
Exercise of pre-funded warrants, value $ 42 467 509
Issuance of common stock to vendor, shares 7,836          
Issuance of common stock to vendor, value $ 7 (7)
Issuance of common stock to adjust for reverse split rounding, shares 1,442          
Issuance of common stock to adjust for reverse split rounding, value $ 1 (1)
Share-based expense 234,154 234,154
Common stock awards to vendors 15,000 15,000
Net loss (1,377,400) (1,377,400)
Ending balance, shares at Jun. 30, 2019 2,774,394 949,218          
Ending balance, value at Jun. 30, 2019 $ 2,774 $ 948 171,352,760 (155,938,245) 253,734 (5,281,180) 10,390,791
Beginning balance, shares at Dec. 31, 2019 2,774,394 6,092,432          
Beginning balance, value at Dec. 31, 2019 $ 2,774 $ 6,092 188,240,451 (166,008,620) 253,734 (5,281,180) 17,213,251
Issuance of common stock to vendor, shares 1,188          
Issuance of common stock to vendor, value $ 1 (1)
Share-based expense 277,332 277,332
Exercise of purchase warrants, shares 229,598          
Exercise of purchase warrants, value $ 229 (229)
Net loss (2,133,071) (2,133,071)
Ending balance, shares at Jun. 30, 2020 2,774,394 6,323,218          
Ending balance, value at Jun. 30, 2020 $ 2,774 $ 6,322 188,517,553 (168,141,691) 253,734 (5,281,180) 15,357,512
Beginning balance, shares at Mar. 31, 2020 2,774,394 6,311,906          
Beginning balance, value at Mar. 31, 2020 $ 2,774 $ 6,311 188,405,830 (167,188,049) 253,734 (5,281,180) 16,199,420
Issuance of common stock to vendor, shares 1,188          
Issuance of common stock to vendor, value $ 1 (1)
Share-based expense 111,734 111,734
Exercise of purchase warrants, shares 10,124          
Exercise of purchase warrants, value $ 10 (10)
Net loss (953,642) (953,642)
Ending balance, shares at Jun. 30, 2020 2,774,394 6,323,218          
Ending balance, value at Jun. 30, 2020 $ 2,774 $ 6,322 $ 188,517,553 $ (168,141,691) $ 253,734 $ (5,281,180) $ 15,357,512